Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Raoul Herbrecht, David W. Denning, Thomas F. Patterson et al. · New England Journal of Medicine · 2002 · 3.3K citations · Full text

Life Sciences, Microbiology, Pharmacology +10

Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis

David W. Denning, Patricia Ribaud, Nöel Milpied et al. · Clinical Infectious Diseases · 2002 · 848 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes

Thomas F. Patterson, William R. Kirkpatrick, Mary H. White et al. · Medicine · 2000 · 790 citations

Life Sciences, Infectious Diseases, Microbiology +17

Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation

J.-A. H. van Burik, V. Ratanatharathorn, Daniel E. Stepan et al. · Clinical Infectious Diseases · 2004 · 742 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy

J. Maertens, Issam Raad, G. Petrikkos et al. · Clinical Infectious Diseases · 2004 · 662 citations · Full text

Medicine, Microbiology, Pharmacology +17